/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

AMLX — Amylyx Pharmaceuticals, Inc. Common Stock

Nasdaq

Amylyx Pharmaceuticals, Inc. Common Stock

Back to Screener
$27.79
-0.29(-1.03%)
O
28.50
H
28.81
L
27.64
V
912.33K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Amylyx Pharmaceuticals, Inc. Common Stock Statistics

Total Valuation

Market Cap$3.76B
Enterprise Value$3.75B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding111.42M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio347.38
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-90.72
EV / Salesn/a
EV / EBITDA-85.74
EV / EBIT-85.55
EV / FCF-101.55

Financial Position

Current Ratio1.79
Quick Ration/a
Debt / Equity0.50
Debt / EBITDA-0.10
Debt / FCF-0.12
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-462.91%
Return on Assets (ROA)-140.61%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-303,559
Employee Count136
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+109.10%
50-Day Moving Average$29.33
200-Day Moving Average$18.52
Relative Strength Index (RSI)21.90
Average Volume (20 Days)1,391,105

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$0
Operating Income-$43.78M
Pretax Income-$41.28M
Net Income-$41.28M
EBITDA-$43.68M
EBIT-$43.78M
Loss Per Share$-0.37

Balance Sheet

Cash & Cash Equivalents$22.91M
Total Debt$4.48M
Net Cash$18.44M
Net Cash Per Share$0.17
Equity (Book Value)$8.92M
Book Value Per Share$0.08
Working Capital$12.54M

Cash Flow

Operating Cash Flow-$31.03M
Capital Expenditures$0
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$36.88M
FCF Per Share$-0.33

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-0.98%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a